Mabwell (Shanghai) Bioscience Co., Ltd.(XSSC:688062) added to S&P Global BMI Index
Mabwell (Shanghai) Bioscience Co., Ltd.
Equities
688062
CNE100005RD2
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
32.8 CNY | -1.18% |
|
-1.80% | +0.34% |
May. 24 | Mabwell Announces 9MW2821 Clinical Data | CI |
May. 13 | Mabwell Announces Clinical Trial Progress of 9MW2821 in Triple-Negative Breast Cancer | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.34% | 1.81B | |
+16.93% | 123B | |
+17.01% | 111B | |
-7.23% | 23.63B | |
+3.35% | 22.58B | |
-14.45% | 17.26B | |
-6.79% | 17.6B | |
-37.63% | 17.61B | |
+2.17% | 13.55B | |
+24.42% | 11.34B |
- Stock Market
- Equities
- 688062 Stock
- News Mabwell (Shanghai) Bioscience Co., Ltd.
- Mabwell Bioscience Co., Ltd.(XSSC: 688062) added to S&P Global BMI Index